combretastatin A4   Click here for help

GtoPdb Ligand ID: 8854

Synonyms: CA-4 | combretastatin A-4 | NSC-613729
PDB Ligand
Compound class: Synthetic organic
Comment: Combretastatin A4 is the active metabolite of 8857. Combretastatin A4 interacts with the colchicine binding site of tubulin, which primarily resides within the β-tubulin subunit, at its interface with the α-subunit [3]. The compound has antineoplastic activity, inhibiting microtubule polymerization, and causing mitotic arrest and apoptosis, particularly targeting the tumour vasculature [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 0
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 57.15
Molecular weight 316.13
XLogP 3.64
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES COc1cc(C=Cc2ccc(c(c2)O)OC)cc(c1OC)OC
Isomeric SMILES COc1cc(/C=C\c2ccc(c(c2)O)OC)cc(c1OC)OC
InChI InChI=1S/C18H20O5/c1-20-15-8-7-12(9-14(15)19)5-6-13-10-16(21-2)18(23-4)17(11-13)22-3/h5-11,19H,1-4H3/b6-5-
No information available.
Summary of Clinical Use Click here for help
Two Phase 2I clinical trials of fosbretabulin in patients with anaplastic thyroid cancer were terminated/withdrawn. Phase 2 trials in other solid tumours, polypoidal choroidal vasculopathy, and age-related macular degeneration (AMD) are ongoing or have been completed.